newsfilter
← Latest News
GlobeNewswire·

Galera Announces Board Approval of Complete Liquidation and Dissolution

MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel, proprietary therapeutics that